Format :LIVE WEBINAR Presenter :Jugna Shah, MPH Event Date : 11/28/2018 Time: 1 pm ET | 12 pm CT | 11 am MT | 10 am PT Duration :60 minutes $249–$449 Each year CMS issues the OPPS final rule, which details the changes to Medicare outpatient coding and billing. The provider must implement and prepare for the rules’ major financial implication by January 1. Last year’s major changes included the reporting of drugs acquired through the 340B drug discount program. Participants will be able to: Have a clear understanding of all of the major changes finalized for OPPS for CY 2019. Know which areas of the final rule are most likely to impact your departments and bottom line. Find out what critical changes are and how to prepare. Understand what site neutral payment policies CMS finalized and the type of analyses needed to model financial impact. Determine which procedures are assigned to comprehensive APCs. Session Agenda: APC recalibration creating financial impact site Neutrality Payment Policy changes including the payment reduction for visit code G0463 and expansion of services in existing Grandfathered Off-Campus provider-based departments Additional On vs. Off-Campus provider-based payment policies Drug pricing changes, including payment of 340B purchased drugs Other drug & radiopharmaceuticals payment changes Packaging Changes Comprehensive APCs and drug administration Information related to Reporting Therapy Modifiers as well as information on new Modifiers Step for computing the financial impact Key changes related to charging, coding, and billing outpatient services Other significant proposals from CMS. Suggested Attendees: Office Managers Administrators Hospital Administrators Finance Directors Health Information Dept. Revenue Cycle Dept. Coding and Billing Staff CDM Managers’ Department Managers Supervisors Compliance Officers Auditors Consultants Industry Organizations About the Presenter: Jugna Shah, MPH is a nationally recognized expert with over 20 years of experience in healthcare financing and regulatory systems. She is a frequent speaker at local, regional, national and international conferences. She is a founder of Nimit Consulting Inc. which specialize in providing information on regulatory initiatives and policies that affect healthcare service delivery, quality, cost, accessibility and compliance. She helps clients address a wide range of needs by analyzing operational and financial challenges, conducting coding, billing, coverage and compliance reviews. Ms. Shah’s areas of specialty include medical and radiation oncology, bone marrow and stem cell transplant billing and reimbursement, new cellular and gene therapies, pharmacy and drug coverage and more.